Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.7 USD | +4.01% | +3.73% | +141.53% |
May. 31 | Sensus Healthcare, Inc. Announces Resignation of John Heinrich from the Board of Directors | CI |
May. 10 | Top MIdday Gainers | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+141.31% | 89.83M | - | ||
-25.12% | 16.64B | A | ||
-45.52% | 2.75B | C+ | ||
+24.57% | 1.94B | - | ||
-10.64% | 1.46B | - | ||
+27.97% | 1.33B | B+ | ||
-14.14% | 966M | - | ||
+4.20% | 796M | - | ||
-29.96% | 788M | - | C- | |
-25.12% | 642M | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SRTS Stock
- Ratings Sensus Healthcare, Inc.